Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations [Biological Sciences]

With the large number of drugs now approved for the treatment of chronic hepatitis C virus (HCV) infection and an even larger number under development, rational identification of effective drug combinations becomes necessary for better disease management and the judicious design of clinical trials. In PNAS, Koizumi et al. (1)...

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2s0OLxU
via IFTTT